Due to the relevant role of JAG1 expression in various aggressive cancers, in this study, we aimed to identify novel specific anti-JAG1 scFvs with the potential for the development of therapeutic products, being either in the antibody format or in a cell modality setting. Here, JAG1 is linked to cancer.